Press Releases

Publication of a Transparency Notification Received from Alychlo
25 February 2022
EN FR

Publication of a Transparency Notification Received from Goldman Sachs
25 February 2022
EN FR

Mithra to Host Webcast for 2021 Financial Results on 8 March 2022
21 February 2022
EN FR

Mithra and Searchlight Pharma Announce Launch of Haloette® in Canada
16 February 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
16 February 2022
EN FR

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase
14 February 2022
EN FR

Mithra Obtains Equity Funding for up to EUR 100 Million
7 February 2022
EN FR

Mithra Announces Positive Top-Line Results from Donesta® Phase 3 Studies in Menopausal Women
14 January 2022
EN FR

Mithra Announces 2022 Financial Calendar
13 January 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
10 January 2022
EN FR

Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
20 December 2021
EN FR

Mayne Pharma and Mithra Announce TGA Approval of Nextstellis® Oral Contraceptive
29 November 2021
EN FR